97859-87-5

Upstream product

• 85828-13-3 (1S,2S,3R,4R)-5-Benzyloxy-3-(tert-butyl-dimethyl-silanyloxy)-1-(4,5-dimethyl-furan-2-yl)-2,4-dimethyl-pentan-1-ol 
• 85828-15-5 (1R,3S,4S,5R)-3-((S)-2-Benzyloxy-1-methyl-ethyl)-1,4,8-trimethyl-2,9-dioxa-bicyclo[3.3.1]non-7-en-6-one 
• 97859-35-3 <4R*(1S*,2S*,4R*,6S*,7R*,8R*),2E>-2-methyl-4-(1,2,7-trimethyl-5-oxo-3,9,10-trioxatricyclo<4.3.1.0(2,4)>dec-8-yl)-2-pentenal 
• 103367-98-2 3-(1-hydroxy-2-(diethoxyphosphinyl)ethylidene)-1-(2,4-dimethoxybenzyl)-2,4-pyrrolidinedion 
• 613-45-6 2,4-Dimethoxybenzaldehyde 
• 103368-51-0 methyl <2E,4E,6R*(1S*-<1α,3α,4β,5α,6α,8β>)>-6-(6-((tert-butyldimethylsilyl)oxy)-1,4,8-trimethyl-2,9-dioxabicyclo<3.3.1>nonan-3-yl)-4-methylhepta-2,4-dienoate 
• 103367-97-1 ethyl N-(4-(diethoxyphosphinyl)-3-oxobutanoyl)-N-(2,4-dimethoxybenzyl)glycinate 
• 103383-27-3 (2E*,4R*,5R*,6R*,7S*,9Z)-5,7-bis((tert-butyldimethylsilyl)oxy)-11,11-dimethoxy-2,4,6,10-tetramethyl-8-oxo-2,9-dodecadienyl acetate 
• 103367-89-1 (1R*(1Z),2S*,3R*,4R*,5S*,6R*)-2,4-bis((tert-butyldimethylsilyl)oxy)-1-(3,3-dimethoxy-2-methyl-1-butenyl)-3,5-dimethyl-6-((trimethylsilyl)oxy)cyclohexan-1-ol 
• 103367-92-6 (2E*,4R*,5R*,6R*,7S*,9Z)-5,7-bis((tert-butyldimethylsilyl)oxy)-11,11-dimethoxy-2,4,6,10-tetramethyl-8-oxo-2,9-dodecadienal 
• 103367-93-7 (2E*,4R*,5R*,6R*,7S*,9Z)-5,7-bis((tert-butyldimethylsilyl)oxy)-11,11-dimethoxy-2,4,6,10-tetramethyl-8-oxo-2,9-dodecadienol 
• 103383-26-2 (1R*(1Z),2R*,3R*,4R*,5R*,6S*)-4,6-bis((tert-butyldimethylsilyl)oxy)-1-(3,3-dimethoxy-2-methyl-1-butenyl)-3,5-dimethylcyclohexan-1,2-diol 
• 103367-90-4 (2R*,3R*,4S*,5R*,7Z)-3,5-bis((tert-butyldimethylsilyl)oxy)-9,9-dimethoxy-2,4,8-trimethyl-6-oxo-7-decenal 
• 103368-54-3 methyl <2E,4E,6R*<1S*-<1α,3α,4β,5α,8β>>>-4-methyl-6-(1,4,8-trimethyl-6-((trimethylsilyl)oxy)-2,9-dioxabicyclo<3.3.1>non-6-en-3-yl)hepta-2,4-dionate 

Relevant academic research and scientific papers

Synthetic Studies Directed toward the Naturally Occurring Acyl Tetramic Acids. 1. Covergent Total Synthesis of (+/-)-Tirandamycin A

An efficient convergent synthetic approach to the structurally unusual tetramic acid antibiotic tirandamycin A is described.Among the key features is the use of a rigid substituted cyclohexanone derivative as a vehicle to assure control of the relative st

Total Synthesis of (+/-)-Tirandamycin A

A convergent, 12-step synthesis of racemic tirandamycin A is described.The key features of the synthesis are preparation of the 2,9-dioxabicyclononane system of the natural product by oxidation of furfuryl alcohol 8a and attachment of the 3-acyl te